Zdrowie i gospodarka · 05/08/2011

FDA Releases Guidance for Small Business Entities on PET Drugs CGMP Compliance

The Food and Drug Administration (FDA) has released a guidance document to assist small businesses in complying with the Current Good Manufacturing Practice (CGMP) regulations for positron emission tomography (PET) drugs, in accordance with the Small Business Regulatory Enforcement Fairness Act. The document aims to provide small businesses with the necessary resources and procedures to ensure compliance with FDA regulations.